PE20050227A1 - Heterociclos biciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion - Google Patents
Heterociclos biciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacionInfo
- Publication number
- PE20050227A1 PE20050227A1 PE2004000561A PE2004000561A PE20050227A1 PE 20050227 A1 PE20050227 A1 PE 20050227A1 PE 2004000561 A PE2004000561 A PE 2004000561A PE 2004000561 A PE2004000561 A PE 2004000561A PE 20050227 A1 PE20050227 A1 PE 20050227A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- phenyl
- compounds
- heterocycles
- bicycle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Abstract
REFERIDA A HETEROCICLOS BICICLICOS DE FORMULA I DONDE Ra ES H, ALQUILO(C1-C3); Rb ES FENILO, 1-FENILETILO; Rc ES (2-HIDROXIETIL)AMINO, N-(2-HIDROXIETIL)-N-(ALQUIL(C1-C3))-AMINO, 2-OXO-OXAZOLIDIN-3-ILO; Rd ES H, HIDROXI, ALQUIL(C1-C3)OXI, ENTRE OTROS; X ES METINO, ENTRE OTROS; n ES 2-4. TAMBIEN REFERIDO AL PROCEDIMIENTO DE PREPARACION DE MEDICAMENTOS QUE CONTIENEN ESTOS COMPUESTOS CUYOS PREFERIDOS SON: (S)-4-[(3-CLORO-4-FLUORO-FENIL)AMINO]-6-[2-(2-OXO-5-METIL-OXAZOLIDIN-3-IL)ETILOXI]-7-METOXI-QUINAZOLINA; (S)-4-[(3-CLORO-4-FLUORO-FENIL)AMINO]-6-{2-[(2-HIDROXI-PROPIL)AMINO]ETILOXI}-7-METOXI-QUINAZOLINA Y 4-[(3-CLORO-4-FLUORO-FENIL)AMINO]-6-[2-(2-OXO-5,5-DIMETIL-OXAZOLIDIN-3-IL)ETILOXI]-7-METOXI-QUINAZOLINA; ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES TUMORALES COMO LA HIPERPLASIA BENIGNA DE PROSTATA (BPH), DE ENFERMEDADES DEL PULMON Y DE LAS VIAS RESPIRATORIAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10326186A DE10326186A1 (de) | 2003-06-06 | 2003-06-06 | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20050227A1 true PE20050227A1 (es) | 2005-05-18 |
Family
ID=33482765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004000561A PE20050227A1 (es) | 2003-06-06 | 2004-06-04 | Heterociclos biciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion |
Country Status (11)
Country | Link |
---|---|
US (3) | US7196091B2 (es) |
EP (1) | EP1641767A2 (es) |
JP (1) | JP2006527176A (es) |
AR (1) | AR044604A1 (es) |
CA (1) | CA2526995A1 (es) |
CL (1) | CL2004001409A1 (es) |
DE (1) | DE10326186A1 (es) |
PE (1) | PE20050227A1 (es) |
TW (1) | TW200510341A (es) |
UY (1) | UY28347A1 (es) |
WO (1) | WO2004108664A2 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE04748B1 (et) | 1999-06-21 | 2006-12-15 | Boehringer Ingelheim Pharma Kg | Bitsüklilised heterotsüklilised ühendid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetodid nende valmistamiseks |
US7019012B2 (en) * | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
DE10204462A1 (de) * | 2002-02-05 | 2003-08-07 | Boehringer Ingelheim Pharma | Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse |
US6924285B2 (en) * | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
DE10221018A1 (de) * | 2002-05-11 | 2003-11-27 | Boehringer Ingelheim Pharma | Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie |
US7456189B2 (en) * | 2003-09-30 | 2008-11-25 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
US20050096332A1 (en) * | 2003-10-30 | 2005-05-05 | Boehringer Ingelheim International Gmbh | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
CA2627590A1 (en) * | 2005-07-04 | 2007-01-11 | Boehringer Ingelheim International Gmbh | Method for the production of quinazolinone derivatives |
WO2007054550A1 (en) | 2005-11-11 | 2007-05-18 | Boehringer Ingelheim International Gmbh | Quinazoline derivatives for the treatment of cancer diseases |
WO2007101782A1 (de) * | 2006-03-09 | 2007-09-13 | Boehringer Ingelheim International Gmbh | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
DK2068880T3 (da) | 2006-09-18 | 2012-07-23 | Boehringer Ingelheim Int | Fremgangsmåde til behandling af cancer, der huser EGFR-mutationer |
EP1921070A1 (de) * | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
WO2008095847A1 (de) * | 2007-02-06 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
WO2009098061A1 (de) | 2008-02-07 | 2009-08-13 | Boehringer Ingelheim International Gmbh | Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
JP5539351B2 (ja) * | 2008-08-08 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法 |
SI2451445T1 (sl) | 2009-07-06 | 2019-07-31 | Boehringer Ingelheim International Gmbh | Postopek za sušenje BIBW2992, njegovih soli in trdnih farmacevtskih formulacij, ki obsegajo to aktivno sestavino |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
CN105399689B (zh) * | 2015-12-03 | 2017-03-01 | 中国人民解放军南京军区南京总医院 | 一种新型喹唑啉衍生物lu1503及其制备方法和应用 |
CN105418517B (zh) * | 2015-12-03 | 2017-03-22 | 中国人民解放军南京军区南京总医院 | 一种新型喹唑啉衍生物lu1509及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
EP0824525B1 (en) * | 1995-04-27 | 2001-06-13 | AstraZeneca AB | Quinazoline derivatives |
DE19911509A1 (de) * | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
AU779695B2 (en) * | 2000-04-07 | 2005-02-10 | Astrazeneca Ab | Quinazoline compounds |
DE10042058A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
US6656946B2 (en) | 2000-08-26 | 2003-12-02 | Boehringer Ingelheim Pharma Kg | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases |
-
2003
- 2003-06-06 DE DE10326186A patent/DE10326186A1/de not_active Withdrawn
-
2004
- 2004-06-02 CA CA002526995A patent/CA2526995A1/en not_active Abandoned
- 2004-06-02 WO PCT/EP2004/005965 patent/WO2004108664A2/de active Application Filing
- 2004-06-02 JP JP2006508256A patent/JP2006527176A/ja active Pending
- 2004-06-02 EP EP04739543A patent/EP1641767A2/de not_active Withdrawn
- 2004-06-03 US US10/860,453 patent/US7196091B2/en active Active
- 2004-06-04 AR ARP040101931A patent/AR044604A1/es not_active Suspension/Interruption
- 2004-06-04 CL CL200401409A patent/CL2004001409A1/es unknown
- 2004-06-04 UY UY28347A patent/UY28347A1/es not_active Application Discontinuation
- 2004-06-04 PE PE2004000561A patent/PE20050227A1/es not_active Application Discontinuation
- 2004-06-04 TW TW093116265A patent/TW200510341A/zh unknown
-
2006
- 2006-07-28 US US11/494,926 patent/US20060264450A1/en not_active Abandoned
-
2010
- 2010-06-30 US US12/826,927 patent/US20100267718A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR044604A1 (es) | 2005-09-21 |
TW200510341A (en) | 2005-03-16 |
US20050014772A1 (en) | 2005-01-20 |
US20060264450A1 (en) | 2006-11-23 |
JP2006527176A (ja) | 2006-11-30 |
CL2004001409A1 (es) | 2005-05-06 |
WO2004108664A3 (de) | 2005-05-26 |
US20100267718A1 (en) | 2010-10-21 |
WO2004108664A2 (de) | 2004-12-16 |
DE10326186A1 (de) | 2004-12-23 |
UY28347A1 (es) | 2005-01-31 |
EP1641767A2 (de) | 2006-04-05 |
US7196091B2 (en) | 2007-03-27 |
CA2526995A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20050227A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
EA201691142A1 (ru) | Ингибиторы мек и способы их применения | |
EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
EA200970611A1 (ru) | Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы | |
CY1108583T1 (el) | Μεθοδος για θεραπεια σοβαρης καρδιακης ανεπαρκειας και φαρμακο για αυτη | |
BRPI0416656A (pt) | compostos de pirrolopirimidina úteis no tratamento do cáncer | |
CA2479786A1 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
EA200801565A1 (ru) | Производные пиримидиниларилмочевины в качестве ингибиторов фактора роста фибробластов ( fgf-фактора ) | |
WO2005044181A2 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
EA200601802A1 (ru) | Производные морфолина | |
DE50310516D1 (de) | Fredericamycin-derivate | |
EA200900388A1 (ru) | Бензоксазолы и оксазолопиридины, применимые в качестве ингибиторов киназ janus | |
NO20072631L (no) | Kreftbehandlingsmetode | |
EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
SE9904176D0 (sv) | New use | |
BRPI0608343A2 (pt) | composto, composição farmacêutica, e, métodos para tratamento ou controle de uma doença ou condição, para intensificação da qualidade do sono, para aumento de sono rem e do sono de onda lenta, para diminuição da fragmentação de padrões do sono, para intensificação de cognição, para aumento da retenção de memória, e, para tratamento, controle, melhora ou redução do risco de esquizofrenia em um paciente mamífero em necessidade destes | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
ES2770047T3 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
WO2005065074A2 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
DE602004005502D1 (de) | Comt-inhibitoren | |
ATE520691T1 (de) | Shp-2-hemmer, pharmazeutische zusammensetzung damit und ihre verwendung zur behandlung phosphatase-vermittelter erkrankungen | |
TN2020000161A1 (en) | CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGIuR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | |
AR026974A1 (es) | N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]-carboxamidas, utiles como inhibidores de cinasas dependientes de ciclina, y las composicionesfarmaceuticas que los contienen | |
ATE444069T1 (de) | Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |